"$227k est for this Q = $64 left in the kitty if they don't over run."
Don't forget that the Research and Development refund was received after this quarter, on Jan 3rd so it isn't shown in the cash on hand in your calculations. That gives management some wiggle room.
"CRL received a further £138,000 Research and Development refund from HMRC on 3 January 2019"
Gives them another $125,000 AUD.
Looks to me that in trying to sell Lochinvar, someone showed interest in taking a stake to fund development, but didn't want the whole thing alone? That seems fair enough, hardly a huge "change of plans" as someone mentioned above... any result at Lochinvar is what we are looking for here in the short term imo.
- Forums
- ASX - By Stock
- NAE
- Ann: Quarterly Activities and Cashflow Report
Ann: Quarterly Activities and Cashflow Report, page-8
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NAE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
0.001(12.5%) |
Mkt cap ! $7.175M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.5¢ | $4.5K | 1M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
34 | 18893837 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 12496705 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2200000 | 0.006 |
9 | 8299899 | 0.005 |
6 | 3650000 | 0.004 |
3 | 2622888 | 0.003 |
3 | 4000100 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 2536904 | 6 |
0.008 | 3066187 | 5 |
0.009 | 1057001 | 6 |
0.010 | 5904545 | 3 |
0.011 | 500000 | 1 |
Last trade - 10.26am 22/11/2024 (20 minute delay) ? |
Featured News
NAE (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online